(136 days)
No
The summary describes standard CT imaging and post-processing techniques (CTA, MPR, volume rendering) and does not mention any AI or ML capabilities. The "Mentions AI, DNN, or ML" field is explicitly marked as "Not Found".
No
The device is described as an X-ray Computed Tomography system used for imaging and diagnosis, not for treatment.
Yes
The "Intended Use / Indications for Use" states that "The device output can provide an aid to diagnosis when used by a qualified physician." This explicitly indicates its role in diagnosis.
No
The device description explicitly lists hardware components such as a Gantry, Operator's Workstation, Patient Table, and high-Frequency X-ray Generator, indicating it is a hardware-based system with integrated software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The SCENARIA Phase 2 system is an X-ray Computed Tomography (CT) system. It uses X-rays to create images of the inside of the body. This is an in vivo imaging technique, meaning it is performed on a living organism.
- Intended Use: The intended use clearly states it is for "head, whole body, cardiac and vascular X-ray Computed Tomography applications in patients of all ages." This involves imaging the patient directly, not analyzing samples taken from the patient.
Therefore, the SCENARIA Phase 2 system falls under the category of medical imaging devices, not in vitro diagnostics.
N/A
Intended Use / Indications for Use
The SCENARIA Phase 2 system is indicated for head, whole body, cardiac and vascular X-ray Computed Tomography applications in patients of all ages. The images can be acquired in either axial, helical, gated or dynamic modes.
The volume datasets acquired by the SCENARIA Phase 2 can be post processed by the SCENARIA Phase 2 to provide additional information. Post processing capabilities included in the SCENARIA Phase 2 software include CT angiography (CTA), Multi-planar reconstruction (MPR) and volume rendering.
Volume datasets acquired by the SCENARIA Phase 2 can be transferred to external devices via a DICOM standard interface.
The guideShot Option adds a remote in-room display and controls to support interventional imaging. The device output can provide an aid to diagnosis when used by a qualified physician.
Product codes
JAK
Device Description
The SCENARIA Phase 2 is a multi-slice computed tomography system that uses x-ray data to produce cross-sectional images of the body at various angles.
The SCENARIA Phase 2 system uses 64-slice CT technology, where the X-ray tube and detector assemblies are mounted on a frame that rotates continuously around the patient using slip ring technology. The solid-state detector assembly design collects up to 64 slices of data simultaneously. The X-ray sub-system features a high frequency generator. X-ray tube, and collimation system that produces a fan beam X-ray output. The system can operate in a helical (spiral) scan mode where the patient table moves during scanning. As the X-ray tube/detector assembly rotates around the patient, data is collected at multiple angles.
The collected data is then reconstructed into cross-sectional images by a high-speed reconstruction sub-system. The images are displayed on a Computer Workstation, stored, printed, and archived as required. The workstation is based on current PC technology using the Windows™ operating system.
The SCENARIA Phase 2 system consists of a Gantry, Operator's Workstation, Patient Table, high-Frequency X-ray Generator, and accessories.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
X-ray Computed Tomography
Anatomical Site
head, whole body, cardiac, vascular
Indicated Patient Age Range
all ages
Intended User / Care Setting
qualified physician
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
A clinical evaluation comparison was conducted with the SCENARIA Phase 2 system and the original SCENARIA System (K101888) and found to be substantially equivalent as documented in Section 12 - Performance Testing - Clinical.
In addition, evaluations were conducted for dose profile, image noise, Modulation Transfer Function (MTF), slice thickness and sensitivity profile, slice plane location, and CT dose index as documented in Section 11 - Performance Testing - Bench.
The evaluation results confirm the performance characteristics of the SCENARIA Phase 2 are comparable to the predicate device and support our conclusion that the SCENARIA Phase 2 system is substantially equivalent.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
SCENARIA Whole-body X-ray CT System (K101888)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.1750 Computed tomography x-ray system.
(a)
Identification. A computed tomography x-ray system is a diagnostic x-ray system intended to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data from the same axial plane taken at different angles. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.
0
K123509
Page 1 of 3
2-2
510(k) Summary of Safety Effectiveness
MAR 29 2013
| Submission Information | |
|---|---|
| Submitter: | Hitachi Medical Systems America, Inc. |
| 1959 Summit Commerce Park | |
| Twinsburg, Ohio 44087-2371 | |
| ph: (330) 425-1313 | |
| fax: (330) 963-0749 | |
| Contact: | Douglas J. Thistlethwaite |
| Date: | November 5, 2012 |
| Establishment Registration No. | 1528028 |
| Trade/Proprietary Name: | SCENARIA Phase 2 Whole-body X-ray CT System |
| Classification Name: | Computed Tomography X-ray System |
| Product Code | JAK |
| C.F.R. Section: | 892.1750 |
| Regulatory Class | Class II |
| Predicate Device(s): | SCENARIA Whole-body X-ray CT System (K101888) |
| Reason for Submission | New Technology |
Device Intended Use
The SCENARIA Phase 2 system is indicated for head, whole body, cardiac and vascular X-ray Computed Tomography applications in patients of all ages. The images can be acquired in either axial, helical, gated or dynamic modes.
The volume datasets acquired by the SCENARIA Phase 2 can be post processed by the SCENARIA Phase 2 to provide additional information. Post processing capabilities included in the SCENARIA Phase 2 software include CT angiography (CTA), Multi-planar reconstruction (MPR) and volume rendering.
Volume datasets acquired by the SCENARIA Phase 2 can be transferred to external devices via a DICOM standard interface.
The guideShot Option adds a remote in-room display and controls to support interventional imaging. The device output can provide an aid to diagnosis when used by a qualified physician.
Device Description
Function
The SCENARIA Phase 2 is a multi-slice computed tomography system that uses x-ray data to produce cross-sectional images of the body at various angles.
1
KB23509
Page 2 of 3
2-3
Scientific Concepts
The SCENARIA Phase 2 system uses 64-slice CT technology, where the X-ray tube and detector assemblies are mounted on a frame that rotates continuously around the patient using slip ring technology. The solid-state detector assembly design collects up to 64 slices of data simultaneously. The X-ray sub-system features a high frequency generator. X-ray tube, and collimation system that produces a fan beam X-ray output. The system can operate in a helical (spiral) scan mode where the patient table moves during scanning. As the X-ray tube/detector assembly rotates around the patient, data is collected at multiple angles.
The collected data is then reconstructed into cross-sectional images by a high-speed reconstruction sub-system. The images are displayed on a Computer Workstation, stored, printed, and archived as required. The workstation is based on current PC technology using the Windows™ operating system.
Physical and Performance Characteristics
The SCENARIA Phase 2 system consists of a Gantry, Operator's Workstation, Patient Table, high-Frequency X-ray Generator, and accessories. The system performance is similar to the predicate device.
Performance Comparison
A clinical evaluation comparison was conducted with the SCENARIA Phase 2 system and the original SCENARIA System (K101888) and found to be substantially equivalent as documented in Section 12 - Performance Testing - Clinical.
In addition, evaluations were conducted for dose profile, image noise, Modulation Transfer Function (MTF), slice thickness and sensitivity profile, slice plane location, and CT dose index as documented in Section 11 - Performance Testing - Bench.
The evaluation results confirm the performance characteristics of the SCENARIA Phase 2 are comparable to the predicate device and support our conclusion that the SCENARIA Phase 2 system is substantially equivalent.
Device Technological Characteristics
The SCENARIA PHASE 2's Gantry, X-ray Tube, X-ray Generator, and Patient Table specifications are the same as the SCENARIA System (K101888). Likewise, the Helical Scanning, Image Processing, Display, Image Storage, and Performance features are equivalent to the predicate device. Lastly, the features related to dose which are available on the predicate device are also included on the SCENARIA PHASE 2. See Section 4 - Comparison to Predicate Device for additional information.
Therefore, the SCENARIA Phase 2 system is technologically equivalent in concept, function, and performance to the predicate device.
2
Safety and Effectiveness
The SCENARIA Phase 2 is designed and manufactured under the Quality System Regulations as outlined in 21 CFR § 820.
Additionally this system is in conformance with the applicable parts of:
- IEC 60601-1, Medical Electrical Equipment Part 1: General Requirements for Safety, . 1988; Amendment 1, 1991-11, Amendment 2, 1995
- . IEC 60601-1-1:2000 Medical Electrical Equipment - Part 1-1: General Requirements for Safety - Collateral Standard; Safety Requirements for Medical Electrical Systems
- IEC 60601-1-2, Medical Electrical Equipment Part 1-2: General Requirements for . Safety - Collateral standard: Electromagnetic Compatibility - Requirements and Tests (Edition 2:2001 with Amendment 1:2004; Edition 2.1 (Edition 2:2001 consolidated with Amendment 1:2004)}
- IEC 60601-1-3: 1994 Edition 1.0, Medical electrical equipment Part 1-3 Collateral . Standard: General Requirements for Radiation Protection in Diagnostic X-ray Equipment.
- IEC 60601-2-32: 1994 Edition 1.0, Medical electrical equipment Part 2: Particular . requirements for the safety of associated equipment of X-ray equipment
- IEC 60601-2-44 (2002-11) Edition 2.1, Medical electrical equipment Part 2-44: . Particular requirements for the safety of X-ray equipment for computed tomography
Conclusions
The SCENARIA Phase 2 system has been developed and validated according to applicable standards. Testing has proven that the system is safe and effective for the indicated use. Risk and hazard analysis shows that there are no new safety issues associated with this system as compared with the predicate device.
3
Image /page/3/Picture/1 description: The image shows the logo for the Department of Health & Human Services (HHS). The logo features a stylized caduceus, a symbol often associated with healthcare, with three wavy lines representing the branches of government. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the caduceus.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
March 29, 2013
Hitachi Medical Systems America, Inc. % Mr. Doug Thistlethwaite Manager. Regulatory Affairs 1959 Summit Commerce Park TWINSBURG OH 44087
Re: K123509
Trade/Device Name: SCENARIA Phase 2 Whole-body X-ray CT System Regulation Number: 21 CFR 892.1750 Regulation Name: Computed tomography x-ray system Regulatory Class: II Product Code: JAK Dated: February 25, 2013 Received: February 26, 2013
Dear Mr. Thistlethwaite:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
4
Page 2 - Mr. Thistlethwaite
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safetv/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industrv/default.htm.
Sincerely yours,
Smh.7)
for
Janine M. Morris Director, Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
5
Indications for Use
510(k) Number (if known): K123509
Device Name:
HITACHI SCENARIA Phase 2 Whole-body X-ray CT System
Indications for Use:
The SCENARIA Phase 2 system is indicated for head, whole body, cardiac and vascular X-ray Computed Tomography applications in patients of all ages. The images can be acquired in either axial, helical, gated or dynamic modes.
The volume datasets acquired by the SCENARIA Phase 2 can be post processed by the SCENARIA Phase 2 to provide additional information. Post processing capabilities included in the SCENARIA Phase 2 software include CT angiography (CTA). Multiplanar reconstruction (MPR) and volume rendering.
Volume datasets acquired by the SCENARIA Phase 2 can be transferred to external devices via a DICOM standard interface.
The guideShot Option adds a remote in-room display and controls to support interventional imaging. The device output can provide an aid to diagnosis when used by a qualified physician.
Prescription Use (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
Sm. 7).
(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health
K123509 510(k)
Page 1 of 1